News Center

Your present location:Home >> Company News >> Otsuka and Japan Kidney Association to Collaborative on Autosomal Dominant Polycystic Kidney Disease

Otsuka and Japan Kidney Association to Collaborative on Autosomal Dominant Polycystic Kidney Disease

Date:2019-6-18

Otsuka Pharmaceutical Co., Ltd. and the Japan Kidney Association, a non-profit organization, have concluded a comprehensive agreement to collaborate in Japan on raising the level of disease awareness and medical care for autosomal dominant polycystic kidney disease (ADPKD), a rare and incurable disease of the kidney.

The Japan Kidney Association and Otsuka will utilize their respective strengths and accumulated experience in the field of nephrology in order to advance the contributions possible to patients with ADPKD and their families.

Chronic kidney diseases impair the healthy lifespans of people afflicted with them. Among them, ADPKD, a hereditary and intractable disease, callsfor earlier diagnosis, prevention of deterioration of the disease, and broader awareness of it among society and the health professions.

TypeInfo: Company News

Keywords for the information:

About Us | Digital Map | Contact Us | Legal Notices | Backstage Management
All rights reserved:Guangdong Otsuka Pharmaceutical Co., Ltd. | "Internet drug information service qualification certificate" :( Guangdong) ─ non-operating ─2009─0035  GuangDong ICP No. 09154721 | Technical Support:www.300.cn
Add: High-tech Industrial Park, Ronggui Street, Shunde District, Foshan City, Guangdong Province, China | Tel:0757-28305861 | Fax:0757-28305862